Literature DB >> 5042701

Isolation and identification of novel sulfur-containing metabolites of spironolactone (Aldactone).

A Karim, E A Brown.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5042701     DOI: 10.1016/0039-128x(72)90117-1

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


× No keyword cloud information.
  14 in total

1.  Canrenoate disposition in dogs. Tissue distribution and elimination.

Authors:  J Kuhlmann; V Kötter; N Rietbrock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-06       Impact factor: 3.000

2.  Conversion of spironolactone to canrenone and disposition kinetics of spironolactone and canrenoate-potassium in rats.

Authors:  W Sadée; U Abshagen; C Finn; N Rietbrock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

3.  Inhibition of aldosterone production in diuretic-induced hyperaldosteronism by aldosterone antagonist canrenone in man.

Authors:  H C Erbler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

4.  Multiple dose kinetics of spironolactone and canrenoate-potassium in cardiac and hepatic failure.

Authors:  W Sadée; R Schröder; E von Leitner; M Dagcioglu
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

5.  Preparation of metabolites of spironolactone by microbial oxygenation.

Authors:  W J Marsheck; A Karim
Journal:  Appl Microbiol       Date:  1973-04

6.  Effect of entekohepatic circulation on the pharmacokinetics of spironolactone in man.

Authors:  U Abshagen; U von Grodzicki; U Hirschberger; H Rennekamp
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-11       Impact factor: 3.000

7.  Pharmacokinetics of spironolactone in man.

Authors:  U Abshagen; H Rennekamp; G Luszpinski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-12       Impact factor: 3.000

Review 8.  Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction.

Authors:  R I Henkin
Journal:  Drug Saf       Date:  1994-11       Impact factor: 5.606

9.  Improved method for comparative evaluation of aldosterone antagonists in healthy man.

Authors:  J Casals-Stenzel; J Schmalbach; W Losert
Journal:  Eur J Clin Pharmacol       Date:  1977-12-02       Impact factor: 2.953

10.  [Cardiac effects of antikaliuretic diuretics-clinical and biochemical investigation (author's transl)].

Authors:  E Erdmann; W Krawietz; D Poppert; R Krüger; T von Arnim; W Vogt; H D Bolte
Journal:  Klin Wochenschr       Date:  1977-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.